|
⚲
|
| Keyboard |
| Anna-Maria & Stephen Kellen Foundation Inc
✚
|
|
|---|---|
| CIK # | 0001722602 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001722602] | |
| 4 | [0001722602] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| X4 Pharmaceuticals Inc | |
| Anna-Maria & Stephen Kellen Foundation Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 98,562 | ||
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 25,819 | ||
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 336,393 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Series C Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 51,813 | $0.00 |